MTOR and glioblastoma: In conclusion, the enrichment of hypoxia and mTORC1 signaling in temozolomide resistant models, as well as enrichment of hypoxia-related gene sets in models susceptible for mTOR inhibitor everolimus indicate a role of mTOR signaling in progression under hypoxic conditions in s.c. GBM PDX (70).